Works matching IS 03407004 AND DT 2019 AND VI 68 AND IP 11
Results: 16
Arginase-1-based vaccination against the tumor microenvironment: the identification of an optimal T-cell epitope.
- Published in:
- Cancer Immunology, Immunotherapy, 2019, v. 68, n. 11, p. 1901, doi. 10.1007/s00262-019-02425-6
- By:
- Publication type:
- Article
Contribution of Fcγ receptor IIB to creating a suppressive tumor microenvironment in a mouse model.
- Published in:
- Cancer Immunology, Immunotherapy, 2019, v. 68, n. 11, p. 1769, doi. 10.1007/s00262-019-02413-w
- By:
- Publication type:
- Article
Neoadjuvant cisplatin and paclitaxel modulate tumor-infiltrating T cells in patients with cervical cancer.
- Published in:
- Cancer Immunology, Immunotherapy, 2019, v. 68, n. 11, p. 1759, doi. 10.1007/s00262-019-02412-x
- By:
- Publication type:
- Article
Lenalidomide improves the therapeutic effect of an interferon-α-dendritic cell-based lymphoma vaccine.
- Published in:
- Cancer Immunology, Immunotherapy, 2019, v. 68, n. 11, p. 1791, doi. 10.1007/s00262-019-02411-y
- By:
- Publication type:
- Article
Clinicopathologic significance of human leukocyte antigen class I expression in patients with stage II and III gastric cancer.
- Published in:
- Cancer Immunology, Immunotherapy, 2019, v. 68, n. 11, p. 1779, doi. 10.1007/s00262-019-02410-z
- By:
- Publication type:
- Article
The prognostic significance of peritumoral tertiary lymphoid structures in breast cancer.
- Published in:
- Cancer Immunology, Immunotherapy, 2019, v. 68, n. 11, p. 1733, doi. 10.1007/s00262-019-02407-8
- By:
- Publication type:
- Article
Monocytes reprogrammed with lentiviral vectors co-expressing GM-CSF, IFN-α2 and antigens for personalized immune therapy of acute leukemia pre- or post-stem cell transplantation.
- Published in:
- Cancer Immunology, Immunotherapy, 2019, v. 68, n. 11, p. 1891, doi. 10.1007/s00262-019-02406-9
- By:
- Publication type:
- Article
Potential clinical application of tumor-infiltrating lymphocyte therapy for ovarian epithelial cancer prior or post-resistance to chemotherapy.
- Published in:
- Cancer Immunology, Immunotherapy, 2019, v. 68, n. 11, p. 1747, doi. 10.1007/s00262-019-02402-z
- By:
- Publication type:
- Article
Understanding TCR affinity, antigen specificity, and cross-reactivity to improve TCR gene-modified T cells for cancer immunotherapy.
- Published in:
- Cancer Immunology, Immunotherapy, 2019, v. 68, n. 11, p. 1881, doi. 10.1007/s00262-019-02401-0
- By:
- Publication type:
- Article
Activation of dendritic cells by targeted DNA: a potential addition to the armamentarium for anti-cancer immunotherapy.
- Published in:
- Cancer Immunology, Immunotherapy, 2019, v. 68, n. 11, p. 1875, doi. 10.1007/s00262-019-02400-1
- By:
- Publication type:
- Article
Antisense targeting of CD47 enhances human cytotoxic T-cell activity and increases survival of mice bearing B16 melanoma when combined with anti-CTLA4 and tumor irradiation.
- Published in:
- Cancer Immunology, Immunotherapy, 2019, v. 68, n. 11, p. 1805, doi. 10.1007/s00262-019-02397-7
- By:
- Publication type:
- Article
CD4<sup>+</sup> T cells indirectly kill tumor cells via induction of cytotoxic macrophages in mouse models.
- Published in:
- Cancer Immunology, Immunotherapy, 2019, v. 68, n. 11, p. 1865, doi. 10.1007/s00262-019-02374-0
- By:
- Publication type:
- Article
Adhering to adhesion: assessing integrin conformation to monitor T cells.
- Published in:
- Cancer Immunology, Immunotherapy, 2019, v. 68, n. 11, p. 1855, doi. 10.1007/s00262-019-02365-1
- By:
- Publication type:
- Article
Naturally occurring cancers in pet dogs as pre-clinical models for cancer immunotherapy.
- Published in:
- Cancer Immunology, Immunotherapy, 2019, v. 68, n. 11, p. 1839, doi. 10.1007/s00262-019-02360-6
- By:
- Publication type:
- Article
The challenges of adoptive cell transfer in the treatment of human renal cell carcinoma.
- Published in:
- Cancer Immunology, Immunotherapy, 2019, v. 68, n. 11, p. 1831, doi. 10.1007/s00262-019-02359-z
- By:
- Publication type:
- Article
Schwann cells shape the neuro-immune environs and control cancer progression.
- Published in:
- Cancer Immunology, Immunotherapy, 2019, v. 68, n. 11, p. 1819, doi. 10.1007/s00262-018-02296-3
- By:
- Publication type:
- Article